Relationship between uric acid and hepatic steatosis among Koreans

Diabetes and Metabolism

Volumn 35, Issue 6, 2009, Pages 447-451

  Lee, K ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

BMI category; Hepatic steatosis; Korean; The metabolic syndrome; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ECHOGRAPHY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERURICEMIA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; DEMOCRATIC PEOPLE'S REPUBLIC OF KOREA; FATTY LIVER; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; OBESITY; PATIENT SELECTION; REGRESSION ANALYSIS;

EID: 71349083886     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.04.011     Document Type: Article

References (17)

1. Baba T., Amasaki Y., Soda M., Hida A., Imaizumi M., Ichimaru S., et al. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertens Res 30 (2007) 823-829
2. Targher G., Bertolini L., Poli F., Rodella S., Scala L., Tessari R., et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54 (2005) 3541-3546
3. Bickel C., Rupprecht H.J., Blankenberg S., Rippin G., Hafner G., Daunhauer A., et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89 (2002) 12-17
4. Fang J., and Alderman M.H. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. JAMA 283 (2000) 2404-2410
5. Feig D.I., Kang D.H., and Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 359 (2008) 1811-1821
6. Park S.H., Kim B.I., Yun J.W., Kim J.W., Park D.I., Cho Y.K., et al. Insulin resistance and C-reactive protein as independent risk factors for nonalcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol 19 (2004) 694-698
7. Chen C.H., Huang M.H., Yang J.C., Nien C.K., Yang C.C., Yeh Y.H., et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in non-obese adults. J Clin Gastroenterol 40 (2006) 745-752
8. Saverymuttu S.H., Joseph A.E., and Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and hepatic steatosis. BMJ 292 (1986) 13-15
9. World Health Organization, International Association for the Study of Obesity International Obesity Task Force. The Asia-Pacific Perspective: Redefining obesity and its treatment. Sydney: Health Communications, 2000.
10. Gomella L.G., and Haist S.A. Clinician's pocket reference. 11th edn (2007), McGraw-Hill Companies Inc, New York, NY
11. Grundy S.M., Brewer Jr. B., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart. Lung and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 109 (2004) 433-438
12. Fan J.G., Saibara T., Chitturi S., Kim B.I., Sung J.J., Chutaputti A., et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?. J Gastroenterol Hepatol 22 (2007) 794-800
13. Watanabe S., Yaginuma R., Ikejima K., and Miyazaki A. Liver diseases and metabolic syndrome. J Gastroenterol 43 (2008) 509-518
14. Nakagawa T., Tuttle K.R., Short R.A., and Johnson R.J. Fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1 (2005) 80-86
15. Karelis A.D., St Pierre D.H., Conus F., Rabasa-Lhoret R., and Poehlman E.T. Metabolic and body composition factors in subgroups of obesity: what do we know?. J Clin Endocrinol Metab 89 (2004) 2569-2575
16. Wildman R.P., Muntner P., Reynolds K., McGinn A.P., Rajpathak S., Wylie-Rosett J., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168 (2008) 1617-1624
17. Deurenberg P., Yap M., and van Staveren W.A. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22 (1998) 1164-1171